Inhibitory Effect on Hexokinase II by Benzimidazoles and the Insight into Interactions
Hillary J. Navarro, Jhawn G. Saul, Andrew E. Huckleby & Sung-Kun Kim · Journal of Pharmaceutical Research International · 2022
Background: Benzimidazoles are aromatic, heterocyclic organic molecules which exhibit pharmacological potential as anti-inflammatory, antiulcer, anti-hypertensive, anticancer agent, and anthelmintic treatments. The benzimidazoles could inhibit human hexokinase II, which is a crit...
Open access
Research Article
10.9734/jpri/2022/v34i43A36311